Pinnacle Financial Group, Inc.’s First Tracks Biotherapeutics TRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAX
Pinnacle Financial Group, Inc.'s TRAX Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in First Tracks Biotherapeutics (TRAX) in Q3 2026: 125 shares worth $4.43K. The stake represents ﹤0.01% of the portfolio and ranks #1816 among its holdings.
180 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.
- Pinnacle Financial Group, Inc. held 125 shares of First Tracks Biotherapeutics worth $4.43K as of Q3 2026.
- First Tracks Biotherapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- First Tracks Biotherapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1816 holding.
- 180 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.